Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns CMSD Q1 2026 Earnings Utility Parent Delivers EPS Beat Notes Edge Higher HRB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Strength EVLV Q1 2026 Earnings Narrow Loss Surprise Lifts Shares SACH Q1 2026 Earnings Massive EPS Surprise Miss Drives Stock Down 25